Poly (AT) Polymorphism in Intron 11 of the XPC DNA Repair Gene Enhances the Risk of Lung Cancer

Reduced DNA repair capacity due to inherited polymorphisms may increase the susceptibility to smoking-related cancers. In this report, we investigate the relationship between xeroderma pigmentosum complementary group C poly (AT) insertion/deletion polymorphism (XPC-PAT) of the XPC gene and lung canc...

Full description

Saved in:

Bibliographic Details
Published in:	Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2004-11, Vol.13 (11), p.1788-1793
Main Authors:	Marin, MSoledad, Lopez-Cima, MFelicitas, Garcia-Castro, Laura, Pascual, Teresa, Marron, Manuel G, Tardon, Adonina
Format:	Article
Language:	eng
Subjects:	Adult Aged Biological and medical sciences Case-Control Studies DNA Repair - genetics DNA-Binding Proteins - genetics Female Genotype Humans Introns - genetics Lung Neoplasms - epidemiology Lung Neoplasms - genetics Lung Neoplasms - pathology Male Medical sciences Middle Aged Pneumology Polymorphism, Genetic Smoking - adverse effects Spain - epidemiology Tumors Tumors of the respiratory system and mediastinum
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Reduced DNA repair capacity due to inherited polymorphisms may increase the susceptibility to smoking-related cancers. In this report, we investigate the relationship between xeroderma pigmentosum complementary group C poly (AT) insertion/deletion polymorphism (XPC-PAT) of the XPC gene and lung cancer risk in a hospital-based case-control study of 359 newly diagnosed lung cancer patients and 375 control subjects matched on age, sex, and catchment area. The XPC genotype was determined by PCR-RFLP, and the results were analyzed using logistic regression, adjusting for relevant covariates. We found that the frequency of the PAT+/+ genotype was higher in the cases (20.6%) than in the controls (14.1%; P = 0.057) and that the PAT+/+ subjects were at significantly increased risk for lung cancer [adjusted odds ratio (OR), 1.60; 95% confidence interval (95% CI), 1.01-2.55]. Stratified analysis revealed that the risk was higher in former smokers (OR, 2.15; 95% CI, 1.07-4.31) and older people (OR, 2.76; 95% CI, 1.02-7.51), although this probably occurs due to 63.4% of cases older than 73 years being ex-smokers. When stratified by histologic type, the variant genotype was associated with statistically significant increased risk for squamous cell carcinoma (OR, 1.93; 95% CI, 1.06-3.51). In conclusion, our findings support the hypothesis that PAT and intron 11 C/A XPC polymorphisms are linked in the Spanish population and may contribute to the risk of developing lung cancer probably due to a higher frequency of deletion of exon 12 and reduced DNA repair capacity of the XPC protein.
ISSN:	1055-9965 1538-7755